Bandingkan Harga & Kinerja Langgeng Makmur Industri Tbk. (LMPI) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Langgeng Makmur Industri Tbk. dan Organon Pharma Indonesia Tbk.: Langgeng Makmur Industri Tbk. diperdagangkan di Rp158 (kapitalisasi pasar 162,37 M, volume 24 jam 354,9 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Langgeng Makmur Industri Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| LMPI | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 162,37 M | 104,4 M |
Volume | 354,9 rb | — |
Lot | 3,55 rb | — |
Perputaran | 56,05 jt | — |
Harga Rata-rata | 157,92 | — |
Nilai Transaksi | 56,05 jt | — |
Harga Ekuilibrium Indikatif | 158 | — |
Volume Ekuilibrium Indikatif | 35 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Langgeng Makmur Industri Tbk.
PT. Langgeng Makmur Industri TBk (the Company) was established under the Domestic Capital Investment Law No. 6 of 1968 as amended by Law No. 12 of 1970, based on the Notarial Deed No. 40 dated November 30, 1972 of Kho Boen Tian, S.H., which was amended by Notarial Deed No. 3 dated January 7, 1976 of the same notary concerning the change in the Company name from PT Langgeng Jaya Plastic Industry Ltd., to PT Langgeng Makmur Plastic Industry Ltd. Based on Notarial Deed No. 450 dated June 27, 1997 of Adam Kasdarmadji, S.H., the Company's name has been changed, to PT Langgeng Makmur Industri Tbk.
Selengkapnya di halaman LMPI →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
